Who owns the IP
The organizations most actively patenting around this compound, ranked by referenced patent volume.
| # | Assignee | Patents |
|---|---|---|
| 1 | Takeda Pharmaceutical Co Ltd | 241 |
| 2 | Grünenthal GmbH | 182 |
| 3 | Capsugel Belgium NV | 101 |
| 4 | Auspex Pharmaceuticals Inc | 82 |
| 5 | Millennium Pharmaceuticals Inc | 77 |
| 6 | F Hoffmann La Roche AG | 68 |
| 7 | Acura Pharmaceuticals Inc | 56 |
| 8 | Nippon Shinyaku Co Ltd | 51 |
| 9 | Johns Hopkins University | 40 |
| 10 | Boehringer Ingelheim Pharma GmbH and Co KG | 39 |
Explore the full landscape
This preview shows the leading assignees. Cypris reveals the full ownership landscape - every filing entity, filing trends, and portfolio momentum.
Visit CyprisWhere innovation is concentrated
Patent classifications ranked by volume reveal the technical domains with the most active filing.
| # | Code | Area | Patents |
|---|---|---|---|
| 1 | A61K | Medicinal preparations | 3,537 |
| 2 | A61P | Therapeutic activity (drug indications) | 2,791 |
| 3 | C07D | Heterocyclic compounds | 871 |
| 4 | C07K | Peptides | 529 |
| 5 | C12N | Microorganisms, enzymes | 384 |
| 6 | G01N | Investigating / analysing materials | 358 |
| 7 | C07C | Acyclic and carbocyclic compounds | 251 |
| 8 | Y02A | Climate change adaptation | 230 |
| 9 | C08L | Polymer compositions (blends) | 219 |
| 10 | C09D | Coatings, paints, varnishes | 153 |
AI mapped opportunity space
This preview shows where patent activity concentrates. Cypris maps the full classification landscape to surface technical whitespace and IP headroom.
See Cypris in actionMost-cited patents
Patents ranked by forward citations reveal the foundational inventions the field continues to build on.
| Title | Year | Assignee | Cited by |
|---|---|---|---|
| PINAVARIUM BROMURE AND MEDAZEPAM COMBINATION FOR IBS TREATMENT | 2017 | ABDI IBRAHIM ILAC SANAYI VE TICARET ANONIM SIRKETI | 1 |
| A COMPRESSED SOLID ORAL DOSAGE FORM COMPRISING PINAVERIUM AND MEDAZEPAM | 2023 | ABDI IBRAHIM ILAC SANAYI VE TICARET ANONIM SIRKETI | 0 |
| FILM COATED TABLET FORMULATIONS CONTAINING BUTYLSCOPOLAMINIUM BROMIDE AND MEDAZEPAM WITH IMPROVED DISSOLVING SPEED | 2022 | WORLD MEDICINE ILAC SAN VE TIC A S | 0 |
| MEDAZEPAM AND PROPANTHELINE COMPOSITION | 1973 | F Hoffmann La Roche AG | 0 |
| PHARMACEUTICAL COMPOSITIONS CONTAINING MEDAZEPAM AND AMITRIPTYLINE | 1970 | SPARAMEDICA AG | 0 |
Where research is gaining momentum
Research themes ranked by publication activity show where scientific interest is accelerating around this compound.
| # | Research topic | Papers |
|---|---|---|
| 1 | Attention Deficit Hyperactivity Disorder | 1 |
| 2 | Electroconvulsive Therapy Studies | 1 |
| 3 | Epilepsy research and treatment | 1 |
| 4 | Foot and Ankle Surgery | 1 |
| 5 | Hypothalamic control of reproductive hormones | 1 |
| 6 | Nitric Oxide and Endothelin Effects | 1 |
Technology trend analysis
Cypris uses AI to connect emerging research themes to IP activity, commercialization signals, and underexplored opportunity areas.
See Cypris in actionWho's driving the science
The most-published authors working with this compound, alongside their primary affiliations.
| # | Author | Affiliation | Papers |
|---|---|---|---|
| 1 | S Manmaru | Tokyo Medical and Dental University | 4 |
| 2 | Т. А. Воронина | Semenov Institute of Chemical Physics | 4 |
| 3 | Christian Stumpf | 3 | |
| 4 | K Náhunek | 3 | |
| 5 | Malcolm Lader | Institute of Psychiatry and Neurology | 3 |
| 6 | Petkov Vv | 3 | |
| 7 | A. O. Shepelyakovskaya | Institute of Bioorganic Chemistry | 2 |
| 8 | Akira Hara | Gifu Pharmaceutical University | 2 |
| 9 | Alyson J. Bond | Institute of Psychiatry and Neurology | 2 |
| 10 | Andrejus Ževžikovas | Kauno Mišku ir Aplinkos Inžinerijos Kolegija | 2 |
Research leaders
This preview lists the top authors. Cypris surfaces the full researcher landscape, their affiliations, and how scientific influence is shifting.
See Cypris in actionThe literature that defines it
The most-cited papers anchoring the scientific record for this compound.
| Title | Year | Cited by | Topic |
|---|---|---|---|
| Barriers to treatment adherence in physiotherapy outpatient clinics: A systematic review | 2010 | 956 | Eating Disorders and Behaviors |
| A systematic review on the effectiveness of physical and rehabilitation interventions for chronic non-specific low back pain | 2010 | 730 | Musculoskeletal pain and rehabilitation |
| Randomised controlled trial of integrated care to reduce disability from chronic low back pain in working and private life | 2010 | 298 | Musculoskeletal pain and rehabilitation |
| Randomised controlled trial of Alexander technique lessons, exercise, and massage (ATEAM) for chronic and recurrent back pain | 2008 | 232 | Musculoskeletal pain and rehabilitation |
| A population-based case–control teratologic study of nitrazepam, medazepam, tofisopam, alprazolum and clonazepam treatment during pregnancy | 2002 | 96 | Folate and B Vitamins Research |
Frequently asked questions
Common questions about this compound's patent and research landscape, answered from the underlying data.
What is the molecular composition of Medazepam?
Which pharmaceutical companies hold the most patents related to Medazepam?
What combination therapies have been patented for Medazepam?
What is the primary research focus in patents covering Medazepam?
Has recent scientific literature studied Medazepam safety during pregnancy?